Image

A Study to Compare Various Root Canal Cleaning Devices Based on Cavitation,Ultrasonic and Conventional Methods.

A Study to Compare Various Root Canal Cleaning Devices Based on Cavitation,Ultrasonic and Conventional Methods.

Recruiting
18-75 years
All
Phase N/A

Powered by AI

Overview

The goal of this clinical trial is to compare the effectiveness of various root canal cleaning devices based on the principle of cavitation, ultrasonics, and conventional methods in a normal healthy adult population aged between 18 to 75 years requiring root canal treatment.

The main question[s] it aims to answer are:

  • Effectiveness of the cleaning mechanism
  • Evaluate the safety of use of the device. Participants will be provided root canal treatment. Participants will be asked to record their post-operative pain levels in a Patient Pain diary. The healing rate of the lesion will be examined at follow-up visits using intraoral X-rays. At the end of the study, a statistical analysis of the clinical outcomes of the root canal treatment will be examined and evaluated in every group.

Description

Study title: "A Comparative Evaluation of Effectiveness in Root Canal Debridement using Inertial Cavitation Device vs Passive Ultrasonic Irrigation and Conventional Preparation: A Randomized Controlled Clinical Trial".

Study Design: This is a prospective, 3-arm randomized, non-blinded, single-center pivotal clinical investigation, performed to evaluate the effectiveness and safety of the Endoclean device with 2 comparator arms.

Primary objective: To test the effectiveness of the Endoclean device for root canal debridement up to 12-month follow-up.

Secondary objective: To test the extended effectiveness and safety of the Endoclean device up to a 24-month follow-up.

Inclusion/Exclusion Criteria:

  1. Inclusion Criteria

•Patients aged between 18-75 years with ASA (American Society of Anesthesiologists) classification 1 and 2.

ASA 1: A normal healthy patient. Example: Fit, non-obese BMI (Body mass index) under 30, a non-smoking patient with good exercise tolerance.

ASA 2: A patient with mild systemic disease. Example: Patient with no functional limitations and a well-controlled disease (e.g., treated hypertension, obesity with BMI under 35, frequent social drinker, or cigarette smoker).

  • Patients who agreed to participate and who have signed the informed consent.
  • Patients presenting with symptomatic and/or asymptomatic apical periodontitis and radiographic evidence of apical periodontitis in anterior or posterior teeth larger than 1.5 mm in diameter.
  • Mature tooth with closed apices
  • Tooth that has never been treated with root canal therapy. 2. Exclusion Criteria:
  • Patients, who have pre-existing health or oral conditions that placed them at risk during the trial.
  • Patients with generalized untreated periodontal disease.
  • Patients with a history of analgesic intake within the past 3 days or antibiotics in the last 1 month.
  • Uncooperative patients
  • Teeth with immature apices, root resorption, or requiring extensive prosthetic rehabilitation.
  • Teeth that cannot be made functional nor restored or difficult to access teeth with no importance (wisdom teeth)
  • Teeth with insufficient periodontal support
  • Teeth with poor prognosis, for example due to deep root caries, large root resorption or open apex cases
  • Fractured teeth
  • Local anatomical factors such as an inaccessible root end
  • Presence of fractured instrument in the root canal
  • Pregnant women
  • Patients unable to understand the study procedure.

Number of Participants:

Total number of participants = 109 subjects Arm 1: 40 subjects Arm 2: 40 subjects Arm 3: 29 subjects Test device: Endoclean (Lumendo AG): hydraulic cavitation cleaning device Control device 1: Passive ultrasonic irrigation (PUI) Control device 2: Rotary files with standard NaOCl irrigation Study duration: 2-3 years The results of the Endoclean group shall be compared to data gathered from the comparator device groups and results shall be presented in the clinical investigation report.

Eligibility

Inclusion Criteria:

        •Patients aged between 18-75 years with ASA (American Society of Anesthesiologists)
        classification 1 and 2.
        ASA 1: A normal healthy patient. Example: Fit, non-obese BMI (Body mass index) under 30, a
        non-smoking patient with good exercise tolerance.
        ASA 2: A patient with mild systemic disease. Example: Patient with no functional
        limitations and a well-controlled disease (e.g., treated hypertension, obesity with BMI
        under 35, frequent social drinker, or cigarette smoker).
          -  Patients who agreed to participate and who have signed the informed consent.
          -  Patients presenting with symptomatic and/or asymptomatic apical periodontitis and
             radiographic evidence of apical periodontitis in anterior or posterior teeth larger
             than 1.5 mm in diameter.
          -  Mature tooth with closed apices
          -  Tooth that has never been treated with root canal therapy.
        Exclusion Criteria:
          -  Patients, who have pre-existing health or oral conditions that placed them at risk
             during the trial.
          -  Patients with generalized untreated periodontal disease.
          -  Patients with a history of analgesic intake within the past 3 days or antibiotics in
             the last 1 month.
          -  Uncooperative patients
          -  Teeth with immature apices, root resorption, or requiring extensive prosthetic
             rehabilitation.
          -  Teeth that cannot be made functional nor restored or difficult to access teeth with no
             importance (wisdom teeth)
          -  Teeth with insufficient periodontal support
          -  Teeth with poor prognosis, for example due to deep root caries, large root resorption
             or open apex cases
          -  Fractured teeth
          -  Local anatomical factors such as an inaccessible root end.
          -  Presence of fractured instrument in the root canal
          -  Pregnant women
          -  Patients unable to understand the study procedure.

Study details
    Apical Periodontitis

NCT06005545

Lumendo AG

26 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.